{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-10-06T12:22:50.957771+00:00",
  "news": [
    {
      "title": "Vertex Pharmaceuticals (VRTX) Highlights Pipeline Progress at BofA Global Healthcare Conference - MSN",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX) Highlights Pipeline Progress at BofA Global Healthcare Conference</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MSN</font>",
      "published": "2025-10-05T23:19:02+00:00",
      "source": "MSN"
    },
    {
      "title": "Final Trades: ServiceNow, Vertex Pharmaceuticals and the IJR - CNBC",
      "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNeEtMbmRVLTdWTFhkTEFwN3N6THh4THpHa0piLXRuS1RDZkRDbWZUV3Y5enMydWNCYUNjRm9rQmNUZHhYQ2ZzQVNzaDBoWUk5aWV4LXB3Zk5sbjUxNEZSdnBNdEZvVngweDlCNlBHcmJLUHpEM0VUZXF6Q2dFNFpVU3MxQXhMVlAySEpGc0VkZ3JMUmV1MHZpMVpPNnJYZmdwZDBr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxNeEtMbmRVLTdWTFhkTEFwN3N6THh4THpHa0piLXRuS1RDZkRDbWZUV3Y5enMydWNCYUNjRm9rQmNUZHhYQ2ZzQVNzaDBoWUk5aWV4LXB3Zk5sbjUxNEZSdnBNdEZvVngweDlCNlBHcmJLUHpEM0VUZXF6Q2dFNFpVU3MxQXhMVlAySEpGc0VkZ3JMUmV1MHZpMVpPNnJYZmdwZDBr?oc=5\" target=\"_blank\">Final Trades: ServiceNow, Vertex Pharmaceuticals and the IJR</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font>",
      "published": "2025-10-02T17:11:00+00:00",
      "source": "CNBC"
    },
    {
      "title": "Vertex Pharmaceuticals (VRTX): Assessing Valuation as Shares Hold Steady and Long-Term Prospects Remain Key - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNVzY1MEJnWVM5LXpkcFBjbm45UVZWWVJtR3hDeFYxVk15YlUwcmd2SFlhTWZmNkpGWjhBMHBBUWJXbGVpcmdKOXBZOFpWb0Noc2pRZGdSdHM1R0Q3LTExdEpDQnV0djR6VlU2YnRrNnFDR3RHbi1idWstcUY3a2VUVG9NZHo2WGxGd2Rnd0hWZ2lvNGJTZ3RXNQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxNVzY1MEJnWVM5LXpkcFBjbm45UVZWWVJtR3hDeFYxVk15YlUwcmd2SFlhTWZmNkpGWjhBMHBBUWJXbGVpcmdKOXBZOFpWb0Noc2pRZGdSdHM1R0Q3LTExdEpDQnV0djR6VlU2YnRrNnFDR3RHbi1idWstcUY3a2VUVG9NZHo2WGxGd2Rnd0hWZ2lvNGJTZ3RXNQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX): Assessing Valuation as Shares Hold Steady and Long-Term Prospects Remain Key</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-03T11:50:46+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals (VRTX): Evaluating Valuation After Recent Steady Share Price Gains - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX): Evaluating Valuation After Recent Steady Share Price Gains</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-10-03T21:49:56+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "2025 Vertex Foundation Scholarship recipients: Real stories and reimagined futures - Vertex Pharmaceuticals",
      "link": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNLTN5U0tyRE9vNThaQi1IeGJ5a2xRdFFwS2ZmRUVtR2l4SllfUGJYZU5zNGVTYnhxRHMwQmh1RWRvczJ2Y3Y5bldpOXNqNTBVRDgzcWV2R2dEZnpCQzFBQWl4eVJ6OHIzTkloNjdJYVEtbkRSWVhxY1VnUERpY2t0Z0VGcGxjcFZJTVlQYjVkdXJsOUlPdnI5VWtteDhVakU4Qk9sdkhVUzU1aUFIRW5tNQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxNLTN5U0tyRE9vNThaQi1IeGJ5a2xRdFFwS2ZmRUVtR2l4SllfUGJYZU5zNGVTYnhxRHMwQmh1RWRvczJ2Y3Y5bldpOXNqNTBVRDgzcWV2R2dEZnpCQzFBQWl4eVJ6OHIzTkloNjdJYVEtbkRSWVhxY1VnUERpY2t0Z0VGcGxjcFZJTVlQYjVkdXJsOUlPdnI5VWtteDhVakU4Qk9sdkhVUzU1aUFIRW5tNQ?oc=5\" target=\"_blank\">2025 Vertex Foundation Scholarship recipients: Real stories and reimagined futures</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals</font>",
      "published": "2025-09-08T07:00:00+00:00",
      "source": "Vertex Pharmaceuticals"
    },
    {
      "title": "1 Reason Wall Street Is Obsessed With Vertex Pharmaceuticals - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPSHpCZ2ZiTk5nRk1CRHNrOXM3VlpibEFXcng3SzBzSmh3NktLSkJkN3haU1NObnZ0cXlRRUVMa0d2YUFVTnpxb0xDREZJWkJYS2RUOFZfeTgxZGxLZ2VNd2RETXBVVnJMeXFQcHNzMzFGR25VSXlQbkJydXBkMFZZRkw0Zm4tNkMtZmtKREptQm5IbVRnZVlCdg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxPSHpCZ2ZiTk5nRk1CRHNrOXM3VlpibEFXcng3SzBzSmh3NktLSkJkN3haU1NObnZ0cXlRRUVMa0d2YUFVTnpxb0xDREZJWkJYS2RUOFZfeTgxZGxLZ2VNd2RETXBVVnJMeXFQcHNzMzFGR25VSXlQbkJydXBkMFZZRkw0Zm4tNkMtZmtKREptQm5IbVRnZVlCdg?oc=5\" target=\"_blank\">1 Reason Wall Street Is Obsessed With Vertex Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-09-15T07:00:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals - Time Magazine",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5\" target=\"_blank\">TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Time Magazine</font>",
      "published": "2025-06-26T07:00:00+00:00",
      "source": "Time Magazine"
    },
    {
      "title": "1 Healthcare Stock with Exciting Potential and 2 Facing Challenges - FinancialContent",
      "link": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxOYVFDVEVFTjVDRG9xT2xxRnlXek9RdjFSU0liWXZKMWpuOWFVYzZkTHJ1Z1JNaVdxSmR6U0pMVjA0YlU4a0xmN2FfQkRjRU12b3JpY01ESE9Kb1JhWERjQmNvVjh4THBzUW8zUmJ0VnJIbk1TTkdTNVI4YWYwSER5TnZTcnF2YUFFak5ocFlsSnZiUVRmSHFfVnhPMmlWWWFGLWNJUEpZeWdVNTFLbC1mVDNwTy0zSk5kSzVrOFJUc1NkcGlRQTlDNHl6TFNUdjdqV2VYRkln?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1gFBVV95cUxOYVFDVEVFTjVDRG9xT2xxRnlXek9RdjFSU0liWXZKMWpuOWFVYzZkTHJ1Z1JNaVdxSmR6U0pMVjA0YlU4a0xmN2FfQkRjRU12b3JpY01ESE9Kb1JhWERjQmNvVjh4THBzUW8zUmJ0VnJIbk1TTkdTNVI4YWYwSER5TnZTcnF2YUFFak5ocFlsSnZiUVRmSHFfVnhPMmlWWWFGLWNJUEpZeWdVNTFLbC1mVDNwTy0zSk5kSzVrOFJUc1NkcGlRQTlDNHl6TFNUdjdqV2VYRkln?oc=5\" target=\"_blank\">1 Healthcare Stock with Exciting Potential and 2 Facing Challenges</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FinancialContent</font>",
      "published": "2025-10-06T04:42:00+00:00",
      "source": "FinancialContent"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals: I'm Downgrading To Hold On Drug Pricing, Pipeline Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOQzRYUXFRSkhaTzlvRWhZSDFkVWs5RlhYNUV4TURuR2NmNFB6U2tvZEpYdFpwZ2VWUk5TekNMQ2tFMUdVS29FMWJBeXI4MW1zcFQzYk83MFRoOEFIdlA4QjJBLWJMZllBazJJX0JYbDdvVXJEZGJiYklTS09YUkNEXzJUbWxmVnZWLUdDcG8yeDJWb2xGcnFqSEwybW9HYWdqWV93SElPS1BqZGFMc0s4ZzFYcjhGaXV1?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOQzRYUXFRSkhaTzlvRWhZSDFkVWs5RlhYNUV4TURuR2NmNFB6U2tvZEpYdFpwZ2VWUk5TekNMQ2tFMUdVS29FMWJBeXI4MW1zcFQzYk83MFRoOEFIdlA4QjJBLWJMZllBazJJX0JYbDdvVXJEZGJiYklTS09YUkNEXzJUbWxmVnZWLUdDcG8yeDJWb2xGcnFqSEwybW9HYWdqWV93SElPS1BqZGFMc0s4ZzFYcjhGaXV1?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: I'm Downgrading To Hold On Drug Pricing, Pipeline Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-09-24T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain - Vertex Pharmaceuticals Newsroom",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5\" target=\"_blank\">(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals Newsroom</font>",
      "published": "2025-01-30T08:00:00+00:00",
      "source": "Vertex Pharmaceuticals Newsroom"
    },
    {
      "title": "Vertex, with new launches gaining steam, boosts revenue forecast despite Trikafta dilemma in Russia - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZ0RxdG8zMm1DUDBpWlFZdk1fMlZBOTlnZi03RTBQYVlKSWRQQ3hNOEhQMUoxVXJRelFTX3RyNkk5X3RwV0IyODkwSVNXR0NHTWVpTHhBRXpvSDAxemJQTjRvWjY2aUpQMXpiNExLRXZ1dkdpY1dudE5FWm10Y1lKVzg3dHcyd2FkZ0RvdlJqSmVJTFFlRS1rbm10aWh2M2lpMnpoVWRWZXVRM1JYeXAxbm9TQ1ZhMWozMWZXY2I1REkwSlE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZ0RxdG8zMm1DUDBpWlFZdk1fMlZBOTlnZi03RTBQYVlKSWRQQ3hNOEhQMUoxVXJRelFTX3RyNkk5X3RwV0IyODkwSVNXR0NHTWVpTHhBRXpvSDAxemJQTjRvWjY2aUpQMXpiNExLRXZ1dkdpY1dudE5FWm10Y1lKVzg3dHcyd2FkZ0RvdlJqSmVJTFFlRS1rbm10aWh2M2lpMnpoVWRWZXVRM1JYeXAxbm9TQ1ZhMWozMWZXY2I1REkwSlE?oc=5\" target=\"_blank\">Vertex, with new launches gaining steam, boosts revenue forecast despite Trikafta dilemma in Russia</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-05-06T07:00:00+00:00",
      "source": "Fierce Pharma"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-10-03",
      "close": 403.29998779296875
    },
    "history": [
      {
        "date": "2025-09-25",
        "close": 381.8699951171875
      },
      {
        "date": "2025-09-26",
        "close": 385.739990234375
      },
      {
        "date": "2025-09-29",
        "close": 395.30999755859375
      },
      {
        "date": "2025-09-30",
        "close": 391.6400146484375
      },
      {
        "date": "2025-10-01",
        "close": 404.2099914550781
      },
      {
        "date": "2025-10-02",
        "close": 408.8500061035156
      },
      {
        "date": "2025-10-03",
        "close": 403.29998779296875
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}